HNRNPA2B1 and amyotrophic lateral sclerosis: Nuclear hnRNPA0 was significantly reduced in FTLD-DN compared to ALS cases (P < 0.05) but no group differences in hnRNPA2B1 or hnRNPH2 were identified (P > 0.1) (Fig. 1).